![]() |
In my first article, I recommended four stocks: Cuno, Consolidated Water (CWCO - commentary - Cramer's Take), Pentair (PNR - commentary - Cramer's Take) and Watts Industries (WTS - commentary - Cramer's Take). Since then, Cuno has been bought out, Watts Industries has been relatively flat, Pentair is down slightly, and Consolidated Water is up roughly 60%. Here are my current thoughts on these names (company data provided by CapitalIQ): Watts Water's products include backflow preventers, fire protection systems, water pressure regulators, water supply and drainage products and temperature/pressure valves. While it has a somewhat significant amount of debt, $316 million, this is equivalent to only 2.5 times EBITDA. When considering its price ratios -- less than 20 times earnings and about 10 times EV/EBITDA -- this company doesn't seem too expensive, given the potential upside of the long-term water bull market.
Consolidated Water uses reverse osmosis technology to produce freshwater from seawater, which it distributes to public utilities, commercial/tourist projects, residential properties and government facilities. Its reverse osmosis technology is an inexpensive way to convert saltwater into a commodity of value, but the stock is pretty expensive: 40 times earnings and 30 times EV/EBITDA. Although I'm not sure the company is worth this valuation, I certainly believe its technology is interesting. Pentair makes products used in the movement, treatment and storage of water, including turbine pumps and light-duty diaphragm pumps. Talk about efficient markets! This company is priced about the same as Watts: 18 times earnings, 10.6 times EV/EBITDA and 2.2 times debt/EBITDA.
Go to NEXT PAGE
At the time of publication, Altucher and/or his fund held none of the issues mentioned, although positions may change at any time. James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of Trade Like a Hedge Fund and Trade Like Warren Buffett. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email. Interested in more writings from James Altucher? Check out his newsletter, TheStreet.com Internet Review. For more information, click here.
Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||||